Syvanne, M; Whittall, RA; Turpeinen, U; Nieminen, MS; Frick, MH; Kesaniemi, YA; ... Taskinen, MR; + view all Syvanne, M; Whittall, RA; Turpeinen, U; Nieminen, MS; Frick, MH; Kesaniemi, YA; Pasternack, A; Humphries, SE; Taskinen, MR; - view fewer (2004) Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis. ATHEROSCLEROSIS , 172 (2) 267 - 272. 10.1016/j.atherosclerosis.2003.10.003.
Full text not available from this repository.
The present study aimed to assess the effect of gemfibrozil on serum total homocysteine (tHcy) concentration and to evaluate the influence of tHcy on the angiographically determined progression of coronary atherosclerosis in a randomised, placebo-controlled trial of 395 post-coronary bypass men with low HDL cholesterol levels. The baseline levels of tHcy and those after 16 months of randomised therapy were measured by high-pressure liquid chromatography. Patients were genotyped for the thermolabile variant of N-5,N-10-methylenetetrahydrofolate reductase (MTHFR) (677C > T substitution). Gemfibrozil therapy was associated with a median 18% increase in tHcy levels (P < 0.001). In the gemfibrozil group increases in tHcy and HDL cholesterol were related (r = 0.217, P = 0.004), but changes in tHcy and triglycerides were not. Levels of tHCy were not associated with baseline extent or progression of coronary-artery disease. Subjects homozygous for the rare MTHFR T allele had 34% higher median tHcy concentrations than CC homozygotes or CT heterozygotes, but responses to gemfibrozil did not differ significantly among genotypes. The MTHFR genotype was not associated with extent or progression of coronary atherosclerosis. We conclude that gemfibrozil causes a significant elevation in tHcy levels, but the clinical relevance of this is unknown at present. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
|Title:||Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis|
|Keywords:||homocysteine, gemfibrozil, coronary-artery disease, METHYLENETETRAHYDROFOLATE REDUCTASE GENE, DENSITY-LIPOPROTEIN CHOLESTEROL, VEIN-GRAFT ATHEROSCLEROSIS, MIDDLE-AGED MEN, PLASMA HOMOCYSTEINE, HEART-DISEASE, VASCULAR-DISEASE, BYPASS SURGERY, ARTERY DISEASE, CARDIOVASCULAR-DISEASE|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only: edit this record